Clinical Trial Update: A Pilot Study of the Use of 129Xe and 1H MRI to Measure the Modulation of Eosinophil-Related Inflammation by Mepolizumab In COPD [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 pilot study using 129Xe and 1H MRI to assess whether mepolizumab modulates eosinophil-related inflammation in chr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Nucala (mepolizumab)

Snippet

Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust | Conditions: COPD | Phase 3 | Status: ACTIVE_NOT_RECRUITING